PATENT CLAIM ANALYSIS

Application Number: 15537087
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["536", "028500"]

Abstract:
This disclosure relates to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.

Claim (Index 22):
A method of treating or preventing MERS coronavirus, Eastern equine encephalitis virus, Western equine encephalitis virus, Venezuelan equine encephalitis virus, Chikungunya virus, and Ross River virus infection, orthomyxoviridae virus or paramyxoviridae virus or RSV virus, or influenza virus, or filoviridae virus or ebola virus infection in a patient comprising administering in effective amount of a compound with the formula: or salt thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.36364
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15204285', '14352176', '15311573', '14234127', '15694982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.658070740323784
- 35 USC 102 Novelty (BERT): 0.5460356847975796
- Combined Prediction Score: 0.6468672347711636
- Mean Citation Score: 419.61694400000016
- Max Citation Score: 435.66403
- Similarity Product: 260.09012877645733

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test